Amgen Inc. (AMGN) CEO Bob Bradway on Q1 2022 Results - Earnings Call Transcript

Amgen Inc. (NASDAQ:AMGN) Q1 2022 Results Conference Call April 27, 2022 5:00 PM ET

Company Participants

Arvind Sood - VP, IR

Bob Bradway - Chairman and CEO

Peter Griffith - CFO

Murdo Gordon - EVP, Global Commercial Operations

David Reese - EVP, Research and Development

Conference Call Participants

Michael Yee - Jefferies

Jay Olson - Oppenheimer

Goeff Meacham - Bank of America

Salveen Richter - Goldman Sachs

Matthew Harrison - Morgan Stanley

Yaron Werber - Cowen & Company

Umer Raffat - Evercore ISI

Carter Gould - Barclays

Robyn Karnauskas - Truist

Mohit Bansal - Wells Fargo

Dane Leone - Raymond James

Evan Seigerman - BMO Capital Markets

Gavin Scott - JPMorgan

Colin Bristow - UBS

Operator

My name is RJ, and I will be your conference facilitator today for Amgen's First Quarter 2022 Financial Results Conference Call. All lines have been placed on mute to prevent any background nose. There will be a question-and-answer session at the conclusion of the last speaker's prepared remarks. In order to ensure that everyone has a chance to participate, we would like to request that you limit yourself to asking one question during the Q&A session. [Operator Instructions]

I would now like to introduce Arvind Sood, Vice President of Investor Relations. Mr. Sood, you may now begin.

Arvind Sood

Okay, RJ. Thank you. Good afternoon, everybody, and welcome to our Q1 call. I think our performance in Q1 exemplifies our continued focus on execution while staying on track to deliver against our long-term objectives. So let's get started.

Slides have been posted. Quick reminder that we'll use non-GAAP financial measures in our presentation and some of the statements will be forward-looking statements. Our SEC filings identify factors that could cause our actual results to vary or differ materially.

So with that, I would like to turn the call over to our Chairman and CEO, Bob Bradway. Bob?

Bob Bradway

Okay. Thank you, Arvind, and hello, everyone, and thank you for joining our call. When we last spoke in February, we told you that we'd be focused on execution and that we have a number of opportunities in place that should enable us to deliver long-term attractive growth.

In the first quarter of the year, we executed well on these many opportunities, delivering 6% revenue growth and 15% earnings per share growth. We achieved this performance despite the effects of COVID during the first two months of the year, currency headwinds, and of course, net selling price declines.